A form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of drugs called mitotic inhibitors.

Loading conversations.
Similar or Related Terms
Statistics
270
Characters
53
Words
61.97
Flesch Reading Ease
9
Flesch Kincaid Grade